Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma
<b>Objective</b> : Oral squamous-cell carcinoma (OSCC) accounts for >90% of oral cancers affecting adults mostly between the fourth to seventh decades of life. The most common OSCC treatment is concomitant chemoradiotherapy (CCRT) having both loco-regional and distant control, but...
Main Authors: | Sadia Minhas, Muhammad Kashif, Wasif Altaf, Nadeem Afzal, Abdul Hanan Nagi |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2017-03-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1032 |
Similar Items
-
Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Ge Hu, et al.
Published: (2023-07-01) -
Comparing the frequency of some oral lesions in prediabetic and healthy individuals: Is there any difference?
by: Akram Ghadiri-Anari, et al.
Published: (2019-01-01) -
Oral lesions in patients with psychiatric disorders
by: Gajić Ivanka, et al.
Published: (2010-01-01) -
Radiation-induced swallowing dysfunction in patients with head and neck cancer: A literature review
by: Yi-Hsiang Chiu, et al.
Published: (2022-01-01) -
Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
by: Chengxin Liu, et al.
Published: (2023-05-01)